Capital Fund Management S.A. Sells 29,924 Shares of Perrigo Company plc (NYSE:PRGO)

Capital Fund Management S.A. reduced its position in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 48.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 31,990 shares of the company's stock after selling 29,924 shares during the period. Capital Fund Management S.A.'s holdings in Perrigo were worth $822,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. MML Investors Services LLC grew its position in shares of Perrigo by 7.7% in the third quarter. MML Investors Services LLC now owns 39,174 shares of the company's stock valued at $1,028,000 after purchasing an additional 2,811 shares during the last quarter. Public Employees Retirement System of Ohio bought a new stake in Perrigo during the 3rd quarter valued at approximately $1,291,000. Barclays PLC grew its holdings in Perrigo by 44.8% in the 3rd quarter. Barclays PLC now owns 120,502 shares of the company's stock valued at $3,160,000 after buying an additional 37,268 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Perrigo by 4.7% during the third quarter. Geode Capital Management LLC now owns 2,359,072 shares of the company's stock worth $61,894,000 after buying an additional 106,356 shares during the last quarter. Finally, Virtu Financial LLC acquired a new position in shares of Perrigo during the third quarter worth approximately $909,000. 95.91% of the stock is currently owned by institutional investors and hedge funds.

Perrigo Stock Performance

PRGO traded up $0.45 during trading on Tuesday, reaching $24.81. 900,084 shares of the company's stock were exchanged, compared to its average volume of 1,522,399. The company has a market capitalization of $3.39 billion, a P/E ratio of -21.20 and a beta of 0.49. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. The business has a 50 day moving average price of $26.49 and a 200 day moving average price of $26.05. Perrigo Company plc has a fifty-two week low of $23.14 and a fifty-two week high of $33.46.

Perrigo (NYSE:PRGO - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.92 by $0.01. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The firm had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.20 billion. As a group, analysts predict that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.

Perrigo Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 25th. Shareholders of record on Friday, March 7th were given a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a yield of 4.68%. This is a boost from Perrigo's previous quarterly dividend of $0.28. The ex-dividend date of this dividend was Friday, March 7th. Perrigo's dividend payout ratio is -92.80%.

Insiders Place Their Bets

In other news, EVP Ronald Craig Janish sold 7,800 shares of Perrigo stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the transaction, the executive vice president now owns 33,666 shares in the company, valued at approximately $923,795.04. The trade was a 18.81 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on PRGO. Piper Sandler lowered shares of Perrigo from an "overweight" rating to a "neutral" rating and dropped their target price for the stock from $34.00 to $27.00 in a research report on Monday, January 6th. StockNews.com lowered shares of Perrigo from a "buy" rating to a "hold" rating in a research report on Wednesday, February 19th. Finally, Argus downgraded Perrigo from a "buy" rating to a "hold" rating in a research report on Tuesday, January 14th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $33.00.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.